Interestingly, although Skp2 deficiency on its own is not sufficient to trigger cellular senescence, it cooperates with Pten loss to trigger a novel p19Arf/p53-independent senescence to restrict cancer development [70]. The gene discussed is TP53; the disease is cancer.